PL2875000T3 - Pochodne aryloetynylowe - Google Patents
Pochodne aryloetynyloweInfo
- Publication number
- PL2875000T3 PL2875000T3 PL13735315T PL13735315T PL2875000T3 PL 2875000 T3 PL2875000 T3 PL 2875000T3 PL 13735315 T PL13735315 T PL 13735315T PL 13735315 T PL13735315 T PL 13735315T PL 2875000 T3 PL2875000 T3 PL 2875000T3
- Authority
- PL
- Poland
- Prior art keywords
- arylethynyl
- derivatives
- arylethynyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12176662 | 2012-07-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2875000T3 true PL2875000T3 (pl) | 2017-03-31 |
Family
ID=48782352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13735315T PL2875000T3 (pl) | 2012-07-17 | 2013-07-12 | Pochodne aryloetynylowe |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US20150133505A1 (pl) |
| EP (1) | EP2875000B1 (pl) |
| JP (1) | JP6089104B2 (pl) |
| KR (1) | KR101631041B1 (pl) |
| CN (1) | CN104364233B (pl) |
| AR (1) | AR091764A1 (pl) |
| AU (1) | AU2013292142B2 (pl) |
| BR (1) | BR112014029015A2 (pl) |
| CA (1) | CA2871389C (pl) |
| CL (1) | CL2014003160A1 (pl) |
| CO (1) | CO7111256A2 (pl) |
| CR (1) | CR20140531A (pl) |
| CY (1) | CY1118205T1 (pl) |
| DK (1) | DK2875000T3 (pl) |
| EA (1) | EA026593B1 (pl) |
| ES (1) | ES2600133T3 (pl) |
| HR (1) | HRP20161691T1 (pl) |
| HU (1) | HUE030177T2 (pl) |
| IL (1) | IL236362A (pl) |
| LT (1) | LT2875000T (pl) |
| MA (1) | MA20150280A2 (pl) |
| MX (1) | MX358998B (pl) |
| MY (1) | MY167810A (pl) |
| NZ (1) | NZ701849A (pl) |
| PE (1) | PE20150184A1 (pl) |
| PH (1) | PH12014502695B1 (pl) |
| PL (1) | PL2875000T3 (pl) |
| PT (1) | PT2875000T (pl) |
| RS (1) | RS55313B1 (pl) |
| SG (1) | SG11201407050UA (pl) |
| SI (1) | SI2875000T1 (pl) |
| TW (1) | TWI473799B (pl) |
| UA (1) | UA114911C2 (pl) |
| WO (1) | WO2014012851A1 (pl) |
| ZA (1) | ZA201408514B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA113223C2 (xx) * | 2012-08-13 | 2016-12-26 | Арилетинілпіримідини | |
| UA114008C2 (xx) * | 2012-10-18 | 2017-04-10 | Похідні етинілу як модулятори активності рецептора mglur5 | |
| AU2016273751B2 (en) * | 2015-06-03 | 2020-04-02 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
| TR201909160T4 (tr) | 2015-07-15 | 2019-07-22 | Hoffmann La Roche | Metabotropik glutamat reseptörü modülatörleri olarak etinil türevleri. |
| WO2018015235A1 (en) | 2016-07-18 | 2018-01-25 | F. Hoffmann-La Roche Ag | Ethynyl derivatives |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19546462A1 (de) * | 1995-12-13 | 1997-06-19 | Bayer Ag | Diarylacetylenketone |
| SI1354875T1 (en) | 2003-05-19 | 2005-02-28 | Les Laboratoires Servier | Method for synthesis of (2S,3aS,7aS)-perhydroindole-2-carboxylic acid and esters thereof; and use in the synthesis of perindopril |
| GB0325956D0 (en) | 2003-11-06 | 2003-12-10 | Addex Pharmaceuticals Sa | Novel compounds |
| EP1809620B1 (en) | 2004-11-04 | 2010-12-29 | Addex Pharma SA | Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| GB0510139D0 (en) | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds B1 |
| KR20100033981A (ko) | 2007-06-03 | 2010-03-31 | 벤더르빌트 유니버시티 | 벤즈아미드 대사성 글루타민산염 수용체5 양성 알로스테릭 조절자 및 이의 제조 및 사용방법 |
| CN101544892B (zh) * | 2009-05-07 | 2012-10-03 | 石家庄诚志永华显示材料有限公司 | 一种合成二芳基乙炔类单体液晶的方法 |
| US8420661B2 (en) | 2010-04-13 | 2013-04-16 | Hoffmann-La Roche Inc. | Arylethynyl derivatives |
| EA022019B1 (ru) * | 2011-04-26 | 2015-10-30 | Ф.Хоффманн-Ля Рош Аг | Этинильные производные в качестве положительных аллостерических модуляторов mglur5 |
-
2013
- 2013-07-12 SI SI201330415A patent/SI2875000T1/sl unknown
- 2013-07-12 EP EP13735315.7A patent/EP2875000B1/en active Active
- 2013-07-12 MA MA37795A patent/MA20150280A2/fr unknown
- 2013-07-12 BR BR112014029015A patent/BR112014029015A2/pt not_active Application Discontinuation
- 2013-07-12 DK DK13735315.7T patent/DK2875000T3/en active
- 2013-07-12 PL PL13735315T patent/PL2875000T3/pl unknown
- 2013-07-12 RS RS20160979A patent/RS55313B1/sr unknown
- 2013-07-12 UA UAA201500231A patent/UA114911C2/uk unknown
- 2013-07-12 HR HRP20161691TT patent/HRP20161691T1/hr unknown
- 2013-07-12 CA CA2871389A patent/CA2871389C/en not_active Expired - Fee Related
- 2013-07-12 PT PT137353157T patent/PT2875000T/pt unknown
- 2013-07-12 CN CN201380031736.9A patent/CN104364233B/zh not_active Expired - Fee Related
- 2013-07-12 SG SG11201407050UA patent/SG11201407050UA/en unknown
- 2013-07-12 MX MX2014014950A patent/MX358998B/es active IP Right Grant
- 2013-07-12 NZ NZ701849A patent/NZ701849A/en not_active IP Right Cessation
- 2013-07-12 ES ES13735315.7T patent/ES2600133T3/es active Active
- 2013-07-12 KR KR1020157001019A patent/KR101631041B1/ko not_active Expired - Fee Related
- 2013-07-12 AU AU2013292142A patent/AU2013292142B2/en not_active Ceased
- 2013-07-12 PE PE2014002231A patent/PE20150184A1/es active IP Right Grant
- 2013-07-12 LT LTEP13735315.7T patent/LT2875000T/lt unknown
- 2013-07-12 JP JP2015521004A patent/JP6089104B2/ja not_active Expired - Fee Related
- 2013-07-12 MY MYPI2014003059A patent/MY167810A/en unknown
- 2013-07-12 WO PCT/EP2013/064747 patent/WO2014012851A1/en not_active Ceased
- 2013-07-12 EA EA201492274A patent/EA026593B1/ru not_active IP Right Cessation
- 2013-07-12 HU HUE13735315A patent/HUE030177T2/en unknown
- 2013-07-15 AR ARP130102507 patent/AR091764A1/es not_active Application Discontinuation
- 2013-07-16 TW TW102125419A patent/TWI473799B/zh not_active IP Right Cessation
-
2014
- 2014-10-23 CO CO14235289A patent/CO7111256A2/es unknown
- 2014-11-19 ZA ZA2014/08514A patent/ZA201408514B/en unknown
- 2014-11-20 CR CR20140531A patent/CR20140531A/es unknown
- 2014-11-21 CL CL2014003160A patent/CL2014003160A1/es unknown
- 2014-12-03 PH PH12014502695A patent/PH12014502695B1/en unknown
- 2014-12-18 IL IL236362A patent/IL236362A/en active IP Right Grant
-
2015
- 2015-01-15 US US14/597,375 patent/US20150133505A1/en not_active Abandoned
- 2015-10-26 US US14/923,308 patent/US9328090B2/en active Active
-
2016
- 2016-11-04 CY CY20161101133T patent/CY1118205T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201409422B (en) | Benzimidazole-proline derivatives | |
| ZA201405486B (en) | Pyridone derivatives | |
| ZA201409273B (en) | Tetrahydropyrazolopyrimidine compounds | |
| ZA201408876B (en) | Pyrrolotriazinone derivatives | |
| AP2015008591A0 (en) | Heterocyclic compounds | |
| LT2838883T (lt) | Nauji feniltetrahidroizochinolino dariniai | |
| ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| IL236295A (en) | The history of indanesulfamide | |
| SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
| IL236362A0 (en) | Arylathinyl history | |
| PT2873660T (pt) | Derivado de indolecarboxamida | |
| ZA201501678B (en) | Arylethynyl derivatives | |
| GB201223187D0 (en) | Formula 1- 2050 | |
| GB201222981D0 (en) | Formula 1 -2050 | |
| GB201222964D0 (en) | Formula 1 - 2050 |